KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Teva Pharmaceutical Industries (TEVA) Inventory Average: 2009-2024

Historic Inventory Average for Teva Pharmaceutical Industries (TEVA) over the last 16 years, with Dec 2024 value amounting to $3.5 billion.

  • Teva Pharmaceutical Industries' Inventory Average fell 13.52% to $3.4 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $3.4 billion, marking a year-over-year decrease of 13.52%. This contributed to the annual value of $3.5 billion for FY2024, which is 10.52% down from last year.
  • Latest data reveals that Teva Pharmaceutical Industries reported Inventory Average of $3.5 billion as of FY2024, which was down 10.52% from $3.9 billion recorded in FY2023.
  • Teva Pharmaceutical Industries' 5-year Inventory Average high stood at $4.4 billion for FY2020, and its period low was $3.5 billion during FY2024.
  • In the last 3 years, Teva Pharmaceutical Industries' Inventory Average had a median value of $3.8 billion in 2022 and averaged $3.8 billion.
  • Per our database at Business Quant, Teva Pharmaceutical Industries' Inventory Average rose by 2.65% in 2023 and then dropped by 10.52% in 2024.
  • Teva Pharmaceutical Industries' Inventory Average (Yearly) stood at $4.4 billion in 2020, then fell by 6.84% to $4.1 billion in 2021, then declined by 6.93% to $3.8 billion in 2022, then rose by 2.65% to $3.9 billion in 2023, then fell by 10.52% to $3.5 billion in 2024.